Search
Search Results
##search.searchResults.foundPlural##
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
3723PDF: 1702HTML: 2688 -
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3199PDF: 1082HTML: 16470 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1229PDF: 859HTML: 3413 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
3042PDF: 638Suppl. Files: 299HTML: 267 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3082PDF: 1620HTML: 358 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2382PDF: 1027HTML: 7691Untitled: 295Fig2: 196Fig3: 192Fig4: 201 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1469PDF: 511HTML: 190 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4406PDF: 1233HTML: 2374Figure 1: 183 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1422PDF: 948HTML: 1674Figure 1: 190 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3392PDF: 601HTML: 714 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1127PDF: 1371HTML: 168 -
- KAWASAKI DISEASE AS THE IMMUNE-MEDIATED ECHO OF A VIRAL INFECTION Kawasaki Disease and Viral Infections
1653PDF: 1001HTML: 669 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
10337PDF: 1010HTML: 297 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4098PDF: 1569HTML: 9246Untitled: 292Untitled: 199Untitled: 184Untitled: 177Untitled: 199Untitled: 355 -
LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA
221PDF: 229Suppl. Files: 23HTML: 6 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3747PDF: 924HTML: 6861 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1709PDF: 1130HTML: 147 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2539PDF: 891HTML: 2399 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2176PDF: 1343HTML: 3509 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1226PDF: 783HTML: 1527Figure 1: 214Figure 2: 205 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1249PDF: 616HTML: 6866







